CALCOCO2 and myeloid sarcoma: Even if these mutations described in NDP52 are completely different, there are some pathological features among diseases in which NDP52 is known to play a role (AD, MS and CD), such as dysfunctional mitochondria, altered gut microbiota, pathogenic infections and inflammation.